NFKB1 and Cognitive impairment: In our study, BML-111 up-regulated the level of SIRT1 and then suppressed the activation of NF-κB and deacetylation of NF-κB p65, which subsequently decreased the activation of microglia, reduced neuroinflammation, improved apoptosis cells and cognitive impairment.